期刊文献+

糖化血红蛋白对老年2型糖尿病的诊断价值研究 被引量:5

原文传递
导出
摘要 目的:探讨糖化血红蛋白(HbA1c)对老年2型糖尿病的诊断价值。方法:从北京市某街道整群随机抽取5个居委会,共调查60岁以上老年人2046例。采用葡萄糖氧化酶法测定血糖水平;高压液相法测定HbA1c。采用受试者工作曲线(ROC曲线)分析HbA1c诊断糖尿病的最佳临界值,并比较HbA1c、口服葡萄糖耐量试验(OGTT)对老年糖尿病的诊断价值。结果:本次调查新发现糖尿病259例,该地区60岁以上老年人糖尿病现患病率30.69%(628/2046)。ROC曲线结果显示,HbA1c诊断老年2型糖尿病的最佳临界值为6.0%,灵敏度和特异性分别为89.5%及72.3%;曲线下面积(AUC)为83.8%,Youden指数显著高于美国糖尿病协会(ADA)推荐的HbA1c≥6.5%(P<0.05);OGTT诊断糖尿病最佳临界值为10.99mmol/L,AUC为97.4%,Youden指数显著高于HbA1c≥6.0%为诊断临界值(P<0.05)。结论:HbA1c用于诊断我国老年糖尿病的最佳临界值为6.0%,但其诊断价值仍低于OGTT≥10.99mmol/L。ADA推荐的HbA1c诊断标准并不适用于我国老年2型糖尿病的诊断与筛查。
出处 《人民军医》 2013年第10期1169-1170,共2页 People's Military Surgeon
  • 相关文献

参考文献7

  • 1Deepa R,Shanthi RS,Premalatha G,et al. Comparison of ADA 1997 and WHO 1985 criteria {or diabetes in south Indians the Chennai Ur- ban Population Study[J]. Am Diabet Assoc Diabet Med, 2000, 17 (12) : 872-874.
  • 2Barr RG,Nathan DM, Meigs JB,et a l. Tests of glycemia for the diag- nosis of type 2 diabetes mellitus[-J]. Ann Intern Med, 2002,137 (4) : 263-272.
  • 3Ameriesn Diabetes AssociatiorLExecutive summary: Standards of medical care in diabetes-2010 [J]. Diabe Care, 2010, 33 (Suppl 1): 4-10.
  • 4杨泽,郑宏,高芳坤,佟之复,于普林,唐雷,史晓红,范钦颖,王秉治,张培兰,曾平.北京地区中老年人糖尿病和IGT患病率与增龄相关性的分析[J].中国糖尿病杂志,2002,10(2):69-73. 被引量:81
  • 5Saudek CD, Herman WH,Sacks DB,et al. A new look at screening and diagnosing diabetes mellitus [J]. Clin Endocrinol Metab, 2008,93 (7) .. 2447-2453.
  • 6张健,杨青,张进安,陈妤,秦秋,杨婧,闫妮.糖化血红蛋白在高危人群诊断2型糖尿病中的价值[J].西安交通大学学报(医学版),2010,31(4):512-514. 被引量:33
  • 7Bao Y, Ma X, Li H, et al. Glycated haemoglobin Alc for diagnosing diabetes in Chinese population:Cross sectional cpidemiological survey [J]. Br Med J,2010,340:c2249.

二级参考文献12

  • 1周翔海,纪立农.空腹血糖和糖化血红蛋白用于筛查糖尿病的研究[J].中华糖尿病杂志(1006-6187),2005,13(3):203-205. 被引量:157
  • 2Diabetes Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J]. N Engl J Med, 2002, 346(6)393-403.
  • 3TUOMILEHTO J, LINDSTROM J, ERIKSSON JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance [J]. N Engl J Med, 2001, 344(18):1343-1350.
  • 4American Diabetes Association. Standards of medical care in diabetes-2007EJ3. Diabetes Care, 2007, 30(1).S2-S41.
  • 5The DECODE-Study Group on behalf of European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies[J]. Diabetologia, 1999, 42(6) :647-654.
  • 6DEEPA R, RANI SS, PREMALATHA G, et al. Comparison of ADA 1997 and WHO 1985 criteria for diabetes in south Indians the Chennai Urban Population Study [J].Am Diabetes Assoc Diabet Med, 2000, 17(12):872-874.
  • 7GOMEZ-PEREZ FJ, AGUILAR-SALINAS CA, LOPEZ-ALVARENGA JC, et al. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose [J]. Diabetes Care, 1998, 21(11) . 1886-1888.
  • 8BENNETT CM, GUO M, DHARMAGE SC. HbAlc as a screening tool for detection of type 2 diabetes: a systematic review [J].Diabetic Med, 2007, 24(4) :333-343.
  • 9KIM KS, KIM SK, LEE YK, et al. Short Report: Diagnostic value of glycated haemoglobin (HbAlc) for the early detection of diabetes in high-risk subjects [J]. Diabetic Meal, 2008, 25 (8) :1464-5491.
  • 10KILPATRICK ES, MAYLOR PW, KEEVIL BG. Biological variation of giycated hemoglobin. Implications for diabetes screening and monitoring[J]. Diabetes Care, 1998, 21(2) :261-264.

共引文献112

同被引文献62

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部